Robin Shandas
Concepts (389)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Models, Cardiovascular | 34 | 2016 | 195 | 3.630 |
Why?
| | Pulmonary Artery | 28 | 2016 | 1134 | 3.160 |
Why?
| | Hypertension, Pulmonary | 25 | 2017 | 1980 | 2.240 |
Why?
| | Ultrasonography | 16 | 2026 | 770 | 2.210 |
Why?
| | Rheology | 9 | 2018 | 94 | 1.860 |
Why?
| | Pulmonary Circulation | 11 | 2017 | 430 | 1.830 |
Why?
| | Blood Flow Velocity | 25 | 2018 | 413 | 1.770 |
Why?
| | Microbubbles | 12 | 2013 | 53 | 1.720 |
Why?
| | Vascular Resistance | 9 | 2017 | 367 | 1.370 |
Why?
| | Image Interpretation, Computer-Assisted | 9 | 2016 | 285 | 1.300 |
Why?
| | Hemorheology | 9 | 2005 | 24 | 1.000 |
Why?
| | Carotid Arteries | 5 | 2017 | 207 | 0.990 |
Why?
| | Upper Gastrointestinal Tract | 1 | 2026 | 12 | 0.970 |
Why?
| | Capsule Endoscopy | 1 | 2026 | 25 | 0.960 |
Why?
| | Algorithms | 10 | 2026 | 1837 | 0.930 |
Why?
| | Hemodynamics | 10 | 2017 | 1121 | 0.920 |
Why?
| | Fontan Procedure | 8 | 2009 | 191 | 0.900 |
Why?
| | Contrast Media | 8 | 2017 | 488 | 0.900 |
Why?
| | Ultrasonography, Doppler | 4 | 2018 | 126 | 0.840 |
Why?
| | Blood Pressure | 14 | 2016 | 1769 | 0.790 |
Why?
| | Surgical Mesh | 2 | 2013 | 50 | 0.780 |
Why?
| | Computer Simulation | 19 | 2018 | 1025 | 0.750 |
Why?
| | Eosinophilia | 1 | 2024 | 221 | 0.700 |
Why?
| | Materials Testing | 6 | 2019 | 354 | 0.700 |
Why?
| | Polymers | 7 | 2018 | 499 | 0.680 |
Why?
| | Echocardiography, Doppler | 5 | 2006 | 115 | 0.670 |
Why?
| | Heart Ventricles | 5 | 2016 | 760 | 0.630 |
Why?
| | Stress, Mechanical | 15 | 2018 | 494 | 0.620 |
Why?
| | Arteries | 6 | 2013 | 259 | 0.620 |
Why?
| | Biomarkers | 2 | 2024 | 4271 | 0.600 |
Why?
| | Bacteria | 1 | 2026 | 889 | 0.590 |
Why?
| | Models, Biological | 7 | 2011 | 1821 | 0.580 |
Why?
| | Laparoscopy | 2 | 2013 | 475 | 0.570 |
Why?
| | Carotid Artery, Common | 1 | 2018 | 31 | 0.550 |
Why?
| | Image Enhancement | 3 | 2009 | 199 | 0.540 |
Why?
| | Gastrointestinal Microbiome | 1 | 2026 | 771 | 0.540 |
Why?
| | Heart Defects, Congenital | 6 | 2007 | 914 | 0.530 |
Why?
| | Models, Theoretical | 7 | 2013 | 582 | 0.520 |
Why?
| | Blood Pressure Determination | 3 | 2008 | 144 | 0.520 |
Why?
| | Image Processing, Computer-Assisted | 5 | 2017 | 780 | 0.510 |
Why?
| | Transducers | 2 | 2009 | 26 | 0.500 |
Why?
| | Patient-Specific Modeling | 1 | 2016 | 45 | 0.490 |
Why?
| | Imaging, Three-Dimensional | 5 | 2013 | 583 | 0.470 |
Why?
| | Compliance | 4 | 2011 | 49 | 0.460 |
Why?
| | Ultrasonics | 3 | 2013 | 50 | 0.460 |
Why?
| | Elasticity | 10 | 2015 | 184 | 0.430 |
Why?
| | Vascular Endothelial Growth Factor A | 5 | 2022 | 557 | 0.420 |
Why?
| | Reproducibility of Results | 12 | 2018 | 3409 | 0.420 |
Why?
| | Elastic Modulus | 3 | 2013 | 121 | 0.410 |
Why?
| | Hernia, Ventral | 1 | 2013 | 22 | 0.410 |
Why?
| | Polyesters | 1 | 2013 | 80 | 0.390 |
Why?
| | Ventricular Dysfunction, Right | 3 | 2015 | 248 | 0.380 |
Why?
| | Ventricular Function, Right | 4 | 2017 | 297 | 0.380 |
Why?
| | Biocompatible Materials | 3 | 2013 | 435 | 0.370 |
Why?
| | Vasodilator Agents | 2 | 2011 | 331 | 0.370 |
Why?
| | Equipment Failure Analysis | 5 | 2013 | 128 | 0.360 |
Why?
| | Elastin | 2 | 2011 | 79 | 0.360 |
Why?
| | Heart-Assist Devices | 2 | 2009 | 567 | 0.350 |
Why?
| | Cattle | 11 | 2017 | 1000 | 0.350 |
Why?
| | Models, Anatomic | 3 | 2018 | 84 | 0.350 |
Why?
| | Magnetic Resonance Imaging | 4 | 2017 | 3863 | 0.340 |
Why?
| | Heart Bypass, Right | 3 | 2006 | 17 | 0.340 |
Why?
| | MicroRNAs | 1 | 2017 | 701 | 0.330 |
Why?
| | Vascular Stiffness | 6 | 2017 | 486 | 0.330 |
Why?
| | Myocardial Perfusion Imaging | 1 | 2011 | 49 | 0.330 |
Why?
| | Ventricular Function, Left | 3 | 2004 | 541 | 0.330 |
Why?
| | Vena Cava, Inferior | 4 | 2006 | 81 | 0.320 |
Why?
| | Ultrasonography, Doppler, Pulsed | 1 | 2010 | 7 | 0.320 |
Why?
| | Ultrasonography, Doppler, Color | 3 | 2010 | 37 | 0.320 |
Why?
| | Shear Strength | 5 | 2017 | 72 | 0.300 |
Why?
| | Micro-Electrical-Mechanical Systems | 1 | 2009 | 6 | 0.300 |
Why?
| | Humans | 58 | 2026 | 144759 | 0.300 |
Why?
| | Uncertainty | 1 | 2010 | 144 | 0.300 |
Why?
| | Numerical Analysis, Computer-Assisted | 4 | 2004 | 18 | 0.300 |
Why?
| | Animals | 33 | 2026 | 38058 | 0.300 |
Why?
| | Miniaturization | 2 | 2009 | 22 | 0.280 |
Why?
| | Vena Cava, Superior | 3 | 2003 | 25 | 0.280 |
Why?
| | Child | 21 | 2018 | 22633 | 0.270 |
Why?
| | Aortic Valve | 2 | 2009 | 365 | 0.270 |
Why?
| | Sensitivity and Specificity | 9 | 2016 | 1985 | 0.270 |
Why?
| | Laser-Doppler Flowmetry | 2 | 2004 | 31 | 0.260 |
Why?
| | Tissue Scaffolds | 3 | 2019 | 223 | 0.260 |
Why?
| | Male | 27 | 2026 | 72315 | 0.260 |
Why?
| | Myocytes, Smooth Muscle | 3 | 2017 | 266 | 0.260 |
Why?
| | Phantoms, Imaging | 4 | 2014 | 158 | 0.250 |
Why?
| | Child, Preschool | 18 | 2017 | 11787 | 0.250 |
Why?
| | Linear Models | 4 | 2007 | 854 | 0.250 |
Why?
| | Heart Septal Defects | 1 | 2006 | 13 | 0.250 |
Why?
| | Gels | 2 | 2018 | 84 | 0.240 |
Why?
| | Pulsatile Flow | 6 | 2012 | 55 | 0.240 |
Why?
| | Female | 26 | 2026 | 78271 | 0.240 |
Why?
| | Vasomotor System | 1 | 2006 | 46 | 0.240 |
Why?
| | In Vitro Techniques | 6 | 2012 | 1047 | 0.240 |
Why?
| | Lung | 4 | 2013 | 4109 | 0.230 |
Why?
| | Pneumothorax | 1 | 2026 | 51 | 0.230 |
Why?
| | Rats | 8 | 2025 | 5597 | 0.230 |
Why?
| | Magnetic Resonance Imaging, Cine | 2 | 2017 | 214 | 0.220 |
Why?
| | Reference Values | 4 | 2018 | 797 | 0.220 |
Why?
| | Tissue Engineering | 3 | 2019 | 442 | 0.220 |
Why?
| | Scattering, Radiation | 4 | 2006 | 103 | 0.220 |
Why?
| | Echocardiography | 3 | 2005 | 652 | 0.210 |
Why?
| | Myocytes, Cardiac | 3 | 2019 | 556 | 0.210 |
Why?
| | Cardiovascular System | 2 | 2006 | 137 | 0.210 |
Why?
| | Diagnosis, Computer-Assisted | 2 | 2005 | 91 | 0.210 |
Why?
| | Connective Tissue | 1 | 2004 | 39 | 0.210 |
Why?
| | Rats, Sprague-Dawley | 6 | 2019 | 2527 | 0.200 |
Why?
| | Breath Tests | 1 | 2024 | 79 | 0.200 |
Why?
| | Physical Stimulation | 1 | 2004 | 68 | 0.200 |
Why?
| | Ventricular Function | 1 | 2004 | 57 | 0.200 |
Why?
| | Energy Transfer | 1 | 2004 | 49 | 0.200 |
Why?
| | Hypoxia | 1 | 2011 | 1199 | 0.200 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2026 | 558 | 0.200 |
Why?
| | Aorta | 2 | 2005 | 429 | 0.200 |
Why?
| | Stroke Volume | 2 | 2017 | 651 | 0.200 |
Why?
| | Crystallization | 1 | 2004 | 145 | 0.200 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2004 | 121 | 0.190 |
Why?
| | Gastritis | 1 | 2024 | 115 | 0.190 |
Why?
| | Animals, Newborn | 5 | 2016 | 902 | 0.190 |
Why?
| | Enteritis | 1 | 2024 | 103 | 0.190 |
Why?
| | Nanotechnology | 1 | 2004 | 126 | 0.190 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2006 | 392 | 0.190 |
Why?
| | Temperature | 4 | 2025 | 679 | 0.190 |
Why?
| | Aortic Coarctation | 1 | 2003 | 79 | 0.180 |
Why?
| | Hydrogels | 3 | 2022 | 700 | 0.180 |
Why?
| | Coronary Angiography | 1 | 2004 | 323 | 0.180 |
Why?
| | Biomechanical Phenomena | 4 | 2013 | 842 | 0.180 |
Why?
| | Neovascularization, Physiologic | 2 | 2020 | 194 | 0.170 |
Why?
| | Muscle, Smooth, Vascular | 2 | 2017 | 452 | 0.170 |
Why?
| | Acrylamides | 2 | 2018 | 70 | 0.160 |
Why?
| | Infant | 10 | 2015 | 10034 | 0.160 |
Why?
| | Cardiac Catheterization | 4 | 2015 | 560 | 0.160 |
Why?
| | Adolescent | 14 | 2017 | 22428 | 0.160 |
Why?
| | Adipose Tissue | 1 | 2025 | 652 | 0.160 |
Why?
| | Delayed-Action Preparations | 2 | 2018 | 183 | 0.160 |
Why?
| | Case-Control Studies | 5 | 2017 | 3604 | 0.160 |
Why?
| | Equipment Design | 4 | 2014 | 530 | 0.150 |
Why?
| | Regional Blood Flow | 6 | 2013 | 514 | 0.150 |
Why?
| | Eosinophilic Esophagitis | 1 | 2024 | 330 | 0.150 |
Why?
| | Hypertension | 1 | 2008 | 1263 | 0.150 |
Why?
| | Biomimetic Materials | 2 | 2017 | 76 | 0.140 |
Why?
| | Angiogenesis Inducing Agents | 1 | 2018 | 26 | 0.140 |
Why?
| | Echocardiography, Three-Dimensional | 1 | 1999 | 71 | 0.140 |
Why?
| | Particle Size | 4 | 2013 | 411 | 0.140 |
Why?
| | Models, Statistical | 3 | 2015 | 681 | 0.140 |
Why?
| | Pilot Projects | 3 | 2026 | 1886 | 0.140 |
Why?
| | Metal Nanoparticles | 1 | 2019 | 85 | 0.140 |
Why?
| | Gold | 1 | 2019 | 115 | 0.140 |
Why?
| | Disease Models, Animal | 4 | 2026 | 4557 | 0.140 |
Why?
| | Pulmonary Wedge Pressure | 2 | 2009 | 67 | 0.130 |
Why?
| | Sulfones | 1 | 2018 | 127 | 0.130 |
Why?
| | Heart Valve Diseases | 1 | 1999 | 151 | 0.130 |
Why?
| | Myocardial Infarction | 2 | 2022 | 1209 | 0.130 |
Why?
| | Swine | 2 | 2026 | 833 | 0.130 |
Why?
| | Bronchoscopy | 1 | 2018 | 227 | 0.130 |
Why?
| | Nanotubes, Carbon | 1 | 2017 | 48 | 0.130 |
Why?
| | Computer-Aided Design | 2 | 2009 | 40 | 0.130 |
Why?
| | Pressure | 4 | 2014 | 225 | 0.120 |
Why?
| | Finite Element Analysis | 3 | 2007 | 67 | 0.120 |
Why?
| | Cardiac Output | 1 | 2016 | 179 | 0.120 |
Why?
| | Laminin | 1 | 2016 | 72 | 0.120 |
Why?
| | Biomimetics | 1 | 2016 | 40 | 0.120 |
Why?
| | Echinococcosis, Pulmonary | 1 | 2015 | 7 | 0.120 |
Why?
| | Drug Carriers | 2 | 2013 | 130 | 0.110 |
Why?
| | Embryonic Stem Cells | 1 | 2016 | 130 | 0.110 |
Why?
| | Acoustics | 2 | 2006 | 48 | 0.110 |
Why?
| | Predictive Value of Tests | 4 | 2015 | 2115 | 0.110 |
Why?
| | Endothelial Cells | 2 | 2012 | 869 | 0.110 |
Why?
| | Arterial Pressure | 1 | 2015 | 136 | 0.110 |
Why?
| | Serum Albumin, Bovine | 1 | 2014 | 62 | 0.110 |
Why?
| | Familial Primary Pulmonary Hypertension | 2 | 2013 | 197 | 0.110 |
Why?
| | Severity of Illness Index | 4 | 2017 | 2925 | 0.100 |
Why?
| | Magnetic Resonance Angiography | 1 | 2016 | 251 | 0.100 |
Why?
| | Bronchi | 1 | 2015 | 267 | 0.100 |
Why?
| | Myocardium | 1 | 2019 | 939 | 0.100 |
Why?
| | Stearic Acids | 1 | 2013 | 16 | 0.100 |
Why?
| | Polyethyleneimine | 1 | 2013 | 18 | 0.100 |
Why?
| | Lysine | 1 | 2016 | 302 | 0.100 |
Why?
| | Airway Extubation | 1 | 2014 | 60 | 0.100 |
Why?
| | Fibroblasts | 1 | 2019 | 1034 | 0.100 |
Why?
| | Cells, Cultured | 7 | 2017 | 4154 | 0.100 |
Why?
| | Phonophoresis | 1 | 2013 | 1 | 0.100 |
Why?
| | Microfluidic Analytical Techniques | 1 | 2013 | 81 | 0.100 |
Why?
| | Heparin | 1 | 2014 | 244 | 0.100 |
Why?
| | Industry | 1 | 2013 | 43 | 0.100 |
Why?
| | Tensile Strength | 1 | 2013 | 96 | 0.090 |
Why?
| | Portal Vein | 1 | 2014 | 114 | 0.090 |
Why?
| | Microspheres | 2 | 2006 | 142 | 0.090 |
Why?
| | Cell Separation | 1 | 2013 | 307 | 0.090 |
Why?
| | Silicon Dioxide | 1 | 2013 | 121 | 0.090 |
Why?
| | Herniorrhaphy | 1 | 2013 | 74 | 0.090 |
Why?
| | Feasibility Studies | 4 | 2015 | 1095 | 0.090 |
Why?
| | Collagen | 2 | 2012 | 456 | 0.090 |
Why?
| | Tetraspanin 28 | 1 | 2012 | 6 | 0.090 |
Why?
| | Time Factors | 4 | 2015 | 7173 | 0.090 |
Why?
| | Coronary Vessels | 2 | 2004 | 251 | 0.090 |
Why?
| | Neural Stem Cells | 1 | 2013 | 166 | 0.090 |
Why?
| | Antineoplastic Agents, Phytogenic | 1 | 2013 | 177 | 0.090 |
Why?
| | Paclitaxel | 1 | 2013 | 255 | 0.090 |
Why?
| | Intubation, Intratracheal | 1 | 2014 | 320 | 0.090 |
Why?
| | Structure-Activity Relationship | 2 | 2013 | 570 | 0.090 |
Why?
| | Sutures | 1 | 2012 | 64 | 0.090 |
Why?
| | Elastic Tissue | 1 | 2011 | 10 | 0.090 |
Why?
| | Fibrillar Collagens | 1 | 2011 | 14 | 0.090 |
Why?
| | Transfection | 1 | 2013 | 940 | 0.080 |
Why?
| | Models, Animal | 1 | 2013 | 392 | 0.080 |
Why?
| | Diagnostic Imaging | 1 | 2014 | 338 | 0.080 |
Why?
| | Angiogenesis Inhibitors | 1 | 2013 | 237 | 0.080 |
Why?
| | Suture Techniques | 1 | 2012 | 131 | 0.080 |
Why?
| | Oscillometry | 2 | 2013 | 35 | 0.080 |
Why?
| | Ophthalmologic Surgical Procedures | 1 | 2012 | 90 | 0.080 |
Why?
| | Arthroplasty | 1 | 2010 | 59 | 0.080 |
Why?
| | Intervertebral Disc Displacement | 1 | 2010 | 41 | 0.080 |
Why?
| | Equipment Failure | 1 | 2010 | 115 | 0.080 |
Why?
| | Prospective Studies | 2 | 2026 | 7990 | 0.080 |
Why?
| | Species Specificity | 1 | 2011 | 574 | 0.080 |
Why?
| | Cell Membrane | 1 | 2013 | 706 | 0.080 |
Why?
| | Electric Capacitance | 1 | 2009 | 6 | 0.080 |
Why?
| | Flow Cytometry | 1 | 2013 | 1173 | 0.080 |
Why?
| | Viscosity | 1 | 2009 | 90 | 0.080 |
Why?
| | Central Venous Pressure | 1 | 2009 | 16 | 0.080 |
Why?
| | Coculture Techniques | 3 | 2019 | 246 | 0.080 |
Why?
| | Endothelial Growth Factors | 1 | 2009 | 64 | 0.070 |
Why?
| | Prostheses and Implants | 1 | 2010 | 141 | 0.070 |
Why?
| | Echocardiography, Doppler, Color | 2 | 2000 | 38 | 0.070 |
Why?
| | Prosthesis Implantation | 1 | 2010 | 153 | 0.070 |
Why?
| | Vasoconstrictor Agents | 1 | 2009 | 144 | 0.070 |
Why?
| | Lipids | 1 | 2013 | 710 | 0.070 |
Why?
| | Mice | 8 | 2022 | 18339 | 0.070 |
Why?
| | Stress, Physiological | 1 | 2012 | 453 | 0.070 |
Why?
| | Hyperbaric Oxygenation | 1 | 2008 | 39 | 0.070 |
Why?
| | Nitric Oxide Synthase Type III | 2 | 2025 | 204 | 0.070 |
Why?
| | Adult | 4 | 2026 | 40449 | 0.070 |
Why?
| | Cell Adhesion Molecules | 1 | 2009 | 178 | 0.070 |
Why?
| | Atherosclerosis | 1 | 2012 | 409 | 0.070 |
Why?
| | Prosthesis Design | 2 | 2007 | 357 | 0.070 |
Why?
| | Reference Standards | 1 | 2008 | 177 | 0.070 |
Why?
| | Internship and Residency | 1 | 2018 | 1257 | 0.070 |
Why?
| | Logistic Models | 2 | 2015 | 2117 | 0.070 |
Why?
| | Middle Aged | 4 | 2018 | 35875 | 0.070 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2013 | 985 | 0.060 |
Why?
| | Nanoparticles | 1 | 2013 | 519 | 0.060 |
Why?
| | Tunica Media | 1 | 2007 | 37 | 0.060 |
Why?
| | Electric Impedance | 1 | 2007 | 111 | 0.060 |
Why?
| | Tunica Intima | 1 | 2007 | 79 | 0.060 |
Why?
| | Vasodilation | 2 | 2025 | 523 | 0.060 |
Why?
| | Probability | 1 | 2007 | 310 | 0.060 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2007 | 151 | 0.060 |
Why?
| | DNA | 1 | 2013 | 1463 | 0.060 |
Why?
| | Aortic Aneurysm, Abdominal | 1 | 2008 | 167 | 0.060 |
Why?
| | Endothelium, Vascular | 2 | 2012 | 965 | 0.060 |
Why?
| | Blood Vessel Prosthesis | 1 | 2007 | 140 | 0.060 |
Why?
| | Nanotubes | 1 | 2006 | 48 | 0.060 |
Why?
| | Cell Differentiation | 1 | 2013 | 2050 | 0.060 |
Why?
| | Aortic Valve Stenosis | 2 | 1999 | 253 | 0.060 |
Why?
| | Venae Cavae | 1 | 2005 | 7 | 0.060 |
Why?
| | Protein Conformation | 1 | 2008 | 946 | 0.060 |
Why?
| | Hemolysis | 1 | 2006 | 243 | 0.050 |
Why?
| | Adipose Tissue, Brown | 1 | 2025 | 59 | 0.050 |
Why?
| | Radiography | 1 | 2007 | 844 | 0.050 |
Why?
| | Computing Methodologies | 1 | 2004 | 3 | 0.050 |
Why?
| | Manufactured Materials | 1 | 2004 | 8 | 0.050 |
Why?
| | Anatomy, Cross-Sectional | 1 | 2004 | 11 | 0.050 |
Why?
| | Adaptation, Physiological | 1 | 2008 | 570 | 0.050 |
Why?
| | Surgery, Computer-Assisted | 1 | 2005 | 84 | 0.050 |
Why?
| | Research Design | 1 | 2010 | 1135 | 0.050 |
Why?
| | Rats, Wistar | 1 | 2025 | 451 | 0.050 |
Why?
| | Rats, Long-Evans | 1 | 2004 | 125 | 0.050 |
Why?
| | Chronic Disease | 1 | 2010 | 1813 | 0.050 |
Why?
| | ROC Curve | 2 | 2015 | 614 | 0.050 |
Why?
| | Quality Control | 1 | 2004 | 163 | 0.050 |
Why?
| | Motion | 1 | 2004 | 100 | 0.050 |
Why?
| | Mitral Valve | 1 | 2004 | 96 | 0.050 |
Why?
| | Tomography, X-Ray Computed | 1 | 2013 | 2730 | 0.050 |
Why?
| | Dogs | 1 | 2004 | 437 | 0.050 |
Why?
| | Antineoplastic Agents | 1 | 2013 | 2194 | 0.050 |
Why?
| | Heart | 1 | 2006 | 636 | 0.040 |
Why?
| | Heart Murmurs | 1 | 2001 | 14 | 0.040 |
Why?
| | Ultrasonography, Interventional | 1 | 2002 | 160 | 0.040 |
Why?
| | Pediatrics | 2 | 2006 | 1114 | 0.040 |
Why?
| | Cytokines | 1 | 2009 | 2061 | 0.040 |
Why?
| | Binomial Distribution | 1 | 2000 | 8 | 0.040 |
Why?
| | RNA, Messenger | 1 | 2009 | 2832 | 0.040 |
Why?
| | Breast Neoplasms | 1 | 2013 | 2452 | 0.040 |
Why?
| | Observer Variation | 1 | 2001 | 355 | 0.040 |
Why?
| | Interleukin-10 | 1 | 2022 | 309 | 0.040 |
Why?
| | Cell Survival | 2 | 2013 | 1098 | 0.040 |
Why?
| | Myosin Heavy Chains | 2 | 2012 | 185 | 0.040 |
Why?
| | Platelet-Derived Growth Factor | 1 | 2020 | 90 | 0.040 |
Why?
| | Mechanotransduction, Cellular | 2 | 2012 | 122 | 0.040 |
Why?
| | Risk Factors | 2 | 2015 | 10779 | 0.040 |
Why?
| | Human Umbilical Vein Endothelial Cells | 1 | 2020 | 108 | 0.040 |
Why?
| | Retrospective Studies | 3 | 2015 | 17066 | 0.040 |
Why?
| | Albumins | 1 | 1999 | 118 | 0.040 |
Why?
| | Actins | 2 | 2012 | 425 | 0.040 |
Why?
| | Cell Line | 2 | 2014 | 2882 | 0.030 |
Why?
| | Injections, Subcutaneous | 1 | 2018 | 164 | 0.030 |
Why?
| | Mitral Valve Stenosis | 1 | 1998 | 20 | 0.030 |
Why?
| | Formative Feedback | 1 | 2018 | 31 | 0.030 |
Why?
| | Mitochondria | 1 | 2025 | 984 | 0.030 |
Why?
| | Prognosis | 2 | 2017 | 4282 | 0.030 |
Why?
| | Gelatin | 1 | 2017 | 56 | 0.030 |
Why?
| | Age Factors | 2 | 2015 | 3333 | 0.030 |
Why?
| | Principal Component Analysis | 1 | 2015 | 197 | 0.030 |
Why?
| | Demography | 1 | 2015 | 288 | 0.030 |
Why?
| | Sulfonic Acids | 1 | 2014 | 17 | 0.030 |
Why?
| | Proton Magnetic Resonance Spectroscopy | 1 | 2014 | 20 | 0.030 |
Why?
| | Area Under Curve | 1 | 2015 | 330 | 0.030 |
Why?
| | Phase Transition | 1 | 2014 | 26 | 0.030 |
Why?
| | Spectroscopy, Fourier Transform Infrared | 1 | 2014 | 88 | 0.030 |
Why?
| | Manikins | 1 | 2014 | 35 | 0.030 |
Why?
| | Constriction, Pathologic | 3 | 2000 | 248 | 0.030 |
Why?
| | Static Electricity | 1 | 2014 | 113 | 0.030 |
Why?
| | Circular Dichroism | 1 | 2014 | 150 | 0.030 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2014 | 199 | 0.030 |
Why?
| | Aging | 1 | 2005 | 1966 | 0.030 |
Why?
| | Myocardial Contraction | 1 | 2015 | 298 | 0.030 |
Why?
| | Cardiography, Impedance | 1 | 2013 | 9 | 0.030 |
Why?
| | Cell Proliferation | 2 | 2013 | 2496 | 0.030 |
Why?
| | Adhesiveness | 1 | 2013 | 18 | 0.030 |
Why?
| | Luciferases, Firefly | 1 | 2013 | 3 | 0.030 |
Why?
| | Patient Positioning | 1 | 2014 | 70 | 0.030 |
Why?
| | Young Adult | 3 | 2015 | 14105 | 0.030 |
Why?
| | Airway Management | 1 | 2014 | 79 | 0.030 |
Why?
| | Porosity | 1 | 2013 | 96 | 0.020 |
Why?
| | MCF-7 Cells | 1 | 2013 | 135 | 0.020 |
Why?
| | Head | 1 | 2014 | 120 | 0.020 |
Why?
| | Sonication | 1 | 2013 | 12 | 0.020 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2013 | 191 | 0.020 |
Why?
| | Trastuzumab | 1 | 2013 | 118 | 0.020 |
Why?
| | Ramipril | 1 | 2012 | 6 | 0.020 |
Why?
| | Cell Death | 1 | 2014 | 383 | 0.020 |
Why?
| | Quantum Dots | 1 | 2013 | 39 | 0.020 |
Why?
| | Peptidyl-Dipeptidase A | 1 | 2012 | 56 | 0.020 |
Why?
| | Mass Screening | 1 | 2001 | 1347 | 0.020 |
Why?
| | Surface Properties | 1 | 2013 | 410 | 0.020 |
Why?
| | Hypertrophy | 1 | 2012 | 127 | 0.020 |
Why?
| | Solubility | 1 | 2013 | 242 | 0.020 |
Why?
| | Plasmids | 1 | 2013 | 379 | 0.020 |
Why?
| | Methylphenazonium Methosulfate | 1 | 2012 | 1 | 0.020 |
Why?
| | Drug Compounding | 1 | 2013 | 107 | 0.020 |
Why?
| | Survival Rate | 1 | 2017 | 2089 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 2013 | 919 | 0.020 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2012 | 178 | 0.020 |
Why?
| | Hyaluronic Acid | 1 | 2013 | 208 | 0.020 |
Why?
| | Microcirculation | 1 | 2012 | 138 | 0.020 |
Why?
| | Treatment Outcome | 4 | 2013 | 11679 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2012 | 427 | 0.020 |
Why?
| | Liposomes | 1 | 2013 | 250 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2014 | 1716 | 0.020 |
Why?
| | Clinical Competence | 1 | 2018 | 1244 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2013 | 1253 | 0.020 |
Why?
| | Thromboxane B2 | 1 | 2009 | 23 | 0.020 |
Why?
| | Prostaglandins F | 1 | 2009 | 15 | 0.020 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2013 | 928 | 0.020 |
Why?
| | Blotting, Western | 1 | 2012 | 1187 | 0.020 |
Why?
| | Hypoxanthine Phosphoribosyltransferase | 1 | 2009 | 24 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2013 | 2027 | 0.020 |
Why?
| | E-Selectin | 1 | 2009 | 61 | 0.020 |
Why?
| | Chemokine CCL2 | 1 | 2009 | 115 | 0.020 |
Why?
| | Sulfonamides | 1 | 2012 | 580 | 0.020 |
Why?
| | Polyethylene Glycols | 1 | 2013 | 654 | 0.020 |
Why?
| | Inflammation | 1 | 2020 | 2878 | 0.020 |
Why?
| | Software | 1 | 2013 | 690 | 0.020 |
Why?
| | Endothelin-1 | 1 | 2009 | 184 | 0.020 |
Why?
| | Cadherins | 1 | 2009 | 201 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2018 | 5992 | 0.020 |
Why?
| | Acrylates | 1 | 2007 | 48 | 0.020 |
Why?
| | Transcriptional Activation | 1 | 2009 | 383 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2009 | 436 | 0.020 |
Why?
| | Extracellular Matrix | 1 | 2011 | 553 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2009 | 1306 | 0.010 |
Why?
| | Antigens, CD | 1 | 2009 | 555 | 0.010 |
Why?
| | Up-Regulation | 1 | 2009 | 851 | 0.010 |
Why?
| | Phosphorylation | 1 | 2009 | 1732 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2013 | 3540 | 0.010 |
Why?
| | Nitric Oxide | 1 | 2009 | 897 | 0.010 |
Why?
| | Apoptosis | 1 | 2013 | 2430 | 0.010 |
Why?
| | Gene Expression | 1 | 2009 | 1490 | 0.010 |
Why?
| | Disease Progression | 1 | 2012 | 2847 | 0.010 |
Why?
| | Regression Analysis | 1 | 2005 | 1003 | 0.010 |
Why?
| | Stents | 1 | 2007 | 556 | 0.010 |
Why?
| | Monitoring, Intraoperative | 1 | 2002 | 64 | 0.010 |
Why?
| | Anastomosis, Surgical | 1 | 2002 | 157 | 0.010 |
Why?
| | Angioplasty, Balloon | 1 | 1999 | 94 | 0.010 |
Why?
| | Veins | 1 | 1998 | 68 | 0.010 |
Why?
| | Cohort Studies | 1 | 2005 | 5960 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2001 | 6429 | 0.000 |
Why?
| | Postoperative Complications | 1 | 2002 | 2919 | 0.000 |
Why?
| | Aged | 1 | 2005 | 25913 | 0.000 |
Why?
|
|
Shandas's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|